Dr. Bettina Hamelin

Dr. Bettina Hamelin, PharmD, EMBA, is a globally renowned researcher and esteemed life sciences executive, who brings over 30 years of experience in academia, industry, and not-for profit organizations to her current role as President of Innovative Medicines Canada (IMC). 

In this role, Dr. Hamelin is dedicated to enhancing access to innovative medicines for Canadians, while advancing Canada’s position as an attractive destination for life sciences investments, high-value jobs, and new clinical trials. Driven by her unwavering commitment to improving the health and well-being of all Canadians, Dr. Hamelin firmly believes collaboration and partnership are essential to the future of healthcare innovation in Canada. Having acquired an Executive MBA in Healthcare from the Sauder School of Business at the University of British Columbia, she is uniquely positioned to work alongside health system stakeholders to find novel solutions to complex challenges.